Working paper

Methods for determining the extent of added benefit - empirical data from dossier assessments

Status
Status: Commission completed
Project no.
GA23-01
Last updated

Report documents

  1. Extract of the working paper

    Methods for determining the extent of added benefit - empirical data from dossier assessments

    published on
    Document type
    PDF document, 804 kB, EN, not accessible
    DOI-Link
    https://doi.org/10.60584/GA23-01_V1.1_en
  2. Working paper

    Methods for determining the extent of added benefit - empirical data from dossier assessments

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/GA23-01_V1.1

Press releases

Determining the extent of added benefit of new drugs in dossier assessments: Have IQWiG's methods worked in practice?

Are the expected effect sizes for the extent of added benefit actually reached in most cases? This was analysed in a recent working paper based on more than 1000 results from over ten years of assessments.

Project details

Project no.
GA23-01
Report type
Working paper
Status
Commission completed
Department/Division
Drug Assessment
DOI

https://doi.org/10.60584/GA23-01_V1.1_en

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form